Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[I Brazilian Guideline for Cardio-Oncology from Sociedade Brasileira de Cardiologia].
Grupo de Estudos em Insuficiência Cardíaca da Sociedade Brasileira de Cardiologia (GEIC/SBC); Sociedade Brasileira de Oncologia Clínica; Instituto do Coração – Faculdade de Medicina da Universidade de São Paulo; Instituto do Câncer do Estado de São Paulo – Faculdade de Medicina da Universidade de São Paulo; Kalil Filho R, Hajjar LA, Bacal F, Hoff PM, Diz Mdel P, Galas FR, Fukushima JT, Almeida JP, Nakamura RE, Trielli TR, Bittar CS, Santos MH, Galdeano FG, Auler Júnior JO, Silvestrini AA, Alencar A, Mota AC, Gusmão CA, Almeida DR, Simões CM, Bocchi EA, Lima EM, Fernandes F, Silveira FS, Vilas-Boas F, Beck da Silva Neto L, Rohde LE, Montera MW, Barbosa M, Mano MS, Riechelmann RS, Arai RJ, Martins SM, Ferreira SM, Santos V. Grupo de Estudos em Insuficiência Cardíaca da Sociedade Brasileira de Cardiologia (GEIC/SBC), et al. Among authors: beck da silva neto l. Arq Bras Cardiol. 2011;96(2 Suppl 1):1-52. Arq Bras Cardiol. 2011. PMID: 21468528 Free article. Portuguese. No abstract available.
Summary of the II Brazilian Guideline update on Acute Heart Failure 2009/2011.
Montera MW, Pereira SB, Colafranceschi AS, Almeida DR, Tinoco EM, Rocha RM, Moura LA, Réa-Neto Á, Mangini S, Braga FG, Albuquerque DC, Stefanini E, Saad EB, Vilas-Boas F, Silva FB, Ramires FJ, Soriano FG, Westphal G, Aguiar Ribeiro GC, Almeida Júnior GL, Villacorta Júnior H, Souza Neto JD, Costa JL, Neto JM, Baracioli LM, Beck da Silva Neto L, Camanho LE, Bittencourt MI, Garcia MI, Consolação Vieira Moreira Md, Moritz RD, Gusmão R, Martins SM, Bordignon S, Fiorelli AI. Montera MW, et al. Among authors: beck da silva neto l. Arq Bras Cardiol. 2012 May;98(5):375-83. doi: 10.1590/s0066-782x2012000500001. Arq Bras Cardiol. 2012. PMID: 22858653 Free article. English, Portuguese.
[II Brazilian Guidelines on Acute Cardiac Insufficiency].
Montera MW, Almeida DR, Tinoco EM, Rocha RM, Moura LA, Réa-Neto Á, Pereira SB, Mangini S, Braga FG, Albuquerque DC, Stefanini E, Saad EB, Vilas-Boas F, Silva FB, Ramires FJ, Soriano FG, Westphal G, Ribeiro GC, Almeida Júnior GL, Júnior HV, Neto JD, Costa JL, Neto JM, Baracioli LM, Beck da Silva Neto L, Camanho LE, Bittencourt MI, Garcia MI, Moreira Mda C, Moritz RD, Gusmão R, Martins SM, Bordignon S, Fiorelli AI. Montera MW, et al. Among authors: beck da silva neto l. Arq Bras Cardiol. 2009;93(3 Suppl 3):2-65. Arq Bras Cardiol. 2009. PMID: 20721452 Free article. Portuguese. No abstract available.
[Orthomolecular medicine based on evidence].
Beck da Silva Neto L, Ribeiro JP. Beck da Silva Neto L, et al. Arq Bras Cardiol. 1997 Jul;69(1):59-60. Arq Bras Cardiol. 1997. PMID: 9532818 Portuguese. No abstract available.
Infectious agents in coronary atherosclerosis.
Beck da Silva Neto L, Ribeiro JP. Beck da Silva Neto L, et al. Arq Bras Cardiol. 1999 Nov;73(5):455-62. doi: 10.1590/s0066-782x1999001100007. Arq Bras Cardiol. 1999. PMID: 10887367 Free article. Review. English, Portuguese. No abstract available.
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Adams KF, Anand I, Arias-Mendoza A, Biering-Sørensen T, Böhm M, Bonderman D, Cleland JGF, Corbalan R, Crespo-Leiro MG, Dahlström U, Echeverria LE, Fang JC, Filippatos G, Fonseca C, Goncalvesova E, Goudev AR, Howlett JG, Lanfear DE, Li J, Lund M, Macdonald P, Mareev V, Momomura SI, O'Meara E, Parkhomenko A, Ponikowski P, Ramires FJA, Serpytis P, Sliwa K, Spinar J, Suter TM, Tomcsanyi J, Vandekerckhove H, Vinereanu D, Voors AA, Yilmaz MB, Zannad F, Sharpsten L, Legg JC, Varin C, Honarpour N, Abbasi SA, Malik FI, Kurtz CE; GALACTIC-HF Investigators. Teerlink JR, et al. N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797. Epub 2020 Nov 13. N Engl J Med. 2021. PMID: 33185990 Free article. Clinical Trial.
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
Bhatt DL, Szarek M, Steg PG, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Voors AA, Metra M, Lund LH, Komajda M, Testani JM, Wilcox CS, Ponikowski P, Lopes RD, Verma S, Lapuerta P, Pitt B; SOLOIST-WHF Trial Investigators. Bhatt DL, et al. N Engl J Med. 2021 Jan 14;384(2):117-128. doi: 10.1056/NEJMoa2030183. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200892 Clinical Trial.
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial.
Szarek M, Bhatt DL, Steg PG, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Voors AA, Metra M, Lund LH, Komajda M, Testani JM, Wilcox CS, Ponikowski P, Lopes RD, Banks P, Tesfaye E, Ezekowitz JA, Verma S, Pitt B; SOLOIST-WHF committees and investigators. Szarek M, et al. Ann Intern Med. 2021 Aug;174(8):1065-1072. doi: 10.7326/M21-0651. Epub 2021 Jun 22. Ann Intern Med. 2021. PMID: 34152828 Clinical Trial.
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.
Verma S, Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Peil B, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Reduced trial committees and investigators. Verma S, et al. Lancet Diabetes Endocrinol. 2022 Jan;10(1):35-45. doi: 10.1016/S2213-8587(21)00292-8. Epub 2021 Nov 30. Lancet Diabetes Endocrinol. 2022. PMID: 34861154
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, Böhm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Gonzalez Juanatey JR, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F; EMPEROR-Reduced Trial Investigators. Packer M, et al. N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28. N Engl J Med. 2020. PMID: 32865377 Free article. Clinical Trial.